ALA+ BioPharma was founded in 2022, based upon the experience of Thomas Hudzik, PhD. During the course of his career as a psychologist, behavioral pharmacologist, psychopharmacologist, project and program leader, toxicologist and neuroscientist, Dr. Hudzik has formed an extensive network of knowledge and colleagues who can help you get the job done correctly.  He is a thought leader in Abuse Potential Assessments and in the discovery and development of new CNS medicines. 

 

We are selective about the clients that we take on, so that every engagement gets the focus it deserves., tailored to the needs of sponsors.